Vita Advisors | Bloomberg

Bloomberg

Monday, April 19, 2010

Pharmaceutical company bonds, the most expensive in the U.S. corporate credit market, face rating cuts after a buyout spree to replace expiring patents

Tags: Drugs, Pharmaceutical

About this site

The information, links and comments made available through this site represents timely content that Vita Advisors, LLC believes is valuable and beneficial to its business constituents, including company executives, financial sponsors, policy makers and regulators, and consultants and thought leaders.

© Copyright 2012, Vita Advisors, LLC. All rights reserved.
See TERMS OF USE

Address

110 Cheshire Lane
Suite 100
Minnetonka, MN 55305

Email

Phone & Fax

Tel: (952) 942-3377
Fax: (952) 942-5696